Mazdutide

Mazdutide is an investigational dual-receptor agonist that targets both GLP-1 (glucagon-like peptide-1) and GCGR (glucagon receptor) to help regulate blood sugar and reduce body weight. Developed primarily for the treatment of obesity and type 2 diabetes, mazdutide enhances insulin secretion, suppresses appetite, and promotes weight loss. It has shown promise in clinical trials, potentially offering an effective option for metabolic health management.